Literature DB >> 32085890

First birth achieved after fertility preservation using vitrification of in vitro matured oocytes in a woman with breast cancer.

M Grynberg1, A Mayeur Le Bras2, L Hesters2, V Gallot3, N Frydman2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32085890     DOI： 10.1016/j.annonc.2020.01.005

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  7 in total

1.  Factors Associated With the Discussion of Fertility Preservation in a Cohort of 1,357 Young Breast Cancer Patients Receiving Chemotherapy.

Authors:  Alice Hours; Aullene Toussaint; Victoire De Castelbajac; Camille Sautter; Julie Borghese; Sophie Frank; Florence Coussy; Enora Laas; Beatriz Grandal; Elise Dumas; Eric Daoud; Julien Guerin; Thomas Balezeau; Jean-Guillaume Feron; Virginie Fourchotte; Youlia Kirova; Florence Lerebours; Jean-Yves Pierga; Eugénie Guillot; Pietro Santulli; Michael Grynberg; Charlotte Sonigo; Emmanuel Reyrat; Pauline Soibinet-Oudot; Fabien Reyal; Anne-Sophie Hamy
Journal:  Front Oncol       Date:  2021-09-28       Impact factor: 6.244

Review 2.  A synopsis of global frontiers in fertility preservation.

Authors:  L M Ataman; M M Laronda; M Gowett; K Trotter; H Anvari; F Fei; A Ingram; M Minette; C Suebthawinkul; Z Taghvaei; M Torres-Vélez; K Velez; S K Adiga; A Anazodo; L Appiah; M T Bourlon; N Daniels; M M Dolmans; C Finlayson; R B Gilchrist; V Gomez-Lobo; E Greenblatt; J A Halpern; K Hutt; E K Johnson; K Kawamura; M Khrouf; D Kimelman; S Kristensen; R T Mitchell; M B Moravek; L Nahata; K E Orwig; M E Pavone; D Pépin; R Pesce; G P Quinn; M P Rosen; E Rowell; K Smith; C Venter; S Whiteside; S Xiao; M Zelinski; K N Goldman; T K Woodruff; F E Duncan
Journal:  J Assist Reprod Genet       Date:  2022-07-23       Impact factor: 3.357

Review 3.  Perspectives on the development and future of oocyte IVM in clinical practice.

Authors:  Michel De Vos; Michaël Grynberg; Tuong M Ho; Ye Yuan; David F Albertini; Robert B Gilchrist
Journal:  J Assist Reprod Genet       Date:  2021-07-03       Impact factor: 3.412

4.  Live birth rate after use of cryopreserved oocytes or embryos at the time of cancer diagnosis in female survivors: a retrospective study of ten years of experience.

Authors:  Charlotte Sonigo; Nelly Frydman; Anne Mayeur; Vincent Puy; Victoria Windal; Laetitia Hesters; Vanessa Gallot; Alexandra Benoit; Michael Grynberg
Journal:  J Assist Reprod Genet       Date:  2021-04-01       Impact factor: 3.357

5.  Double-in vitro maturation increases the number of vitrified oocytes available for fertility preservation when ovarian stimulation is unfeasible.

Authors:  Nathalie Sermondade; Michaël Grynberg; Marjorie Comtet; Constance Valdelievre; Christophe Sifer; Charlotte Sonigo
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.379

6.  Fertility preservation in female patients with hematological disorders.

Authors:  Dan Wu; Huan Shen
Journal:  BMC Pregnancy Childbirth       Date:  2022-01-22       Impact factor: 3.007

7.  In vitro maturation of immature oocytes for fertility preservation in cancer patients compared to control patients with fertility problems in an in vitro fertilization program.

Authors:  Irma Virant-Klun; Jure Bedenk; Nina Jancar
Journal:  Radiol Oncol       Date:  2021-12-22       Impact factor: 2.991
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.